Search

Pharmagest Interactive

Atidarymo kaina

0

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-1.8M

17M

Pardavimai

7.2M

116M

P/E

Sektoriaus vid.

17.552

Dividendų pajamingumas

2.99

Pelno marža

14.879

Darbuotojai

1,400

EBITDA

178M

116M

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

2.99%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

23M

631M

Ankstesnė atidarymo kaina

0

Ankstesnė uždarymo kaina

0

Pharmagest Interactive Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-20 23:07; UTC

Rinkos pokalbiai

Evidence Of Broad Australian Economic Upswing Mounts -- Market Talk

2025-11-20 22:22; UTC

Rinkos pokalbiai

Auckland Airport Has Edge Over Transurban In Infrastructure Stocks -- Market Talk

2025-11-20 22:08; UTC

Rinkos pokalbiai

Revenues of Texas Battery Projects Drop Sharply -- Market Talk

2025-11-20 21:57; UTC

Uždarbis

Walmart Reports Strong Sales Growth, Raises Outlook -- 5th Update

2025-11-20 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-11-20 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-11-20 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2025-11-20 21:50; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2025-11-20 21:31; UTC

Uždarbis

Nvidia's Strong Results Show AI Fears Are Premature -- Update

2025-11-20 21:23; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

2025-11-20 21:07; UTC

Uždarbis

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

2025-11-20 21:06; UTC

Uždarbis

Webull 3Q Rev $156.9M >BULL

2025-11-20 21:06; UTC

Uždarbis

Webull 3Q EPS 7c >BULL

2025-11-20 21:05; UTC

Uždarbis

Intuit 1Q Sales Jump, CFO Cites AI Demand From Mid-Sized Businesses -- Interview

2025-11-20 21:04; UTC

Uždarbis

Mid-Sized Businesses Want to Automate Tasks With AI, Intuit CFO Says >INTU

2025-11-20 21:04; UTC

Uždarbis

Intuit's AI Offerings Attracted More Mid-Sized Businesses in 1Q, CFO Says >INTU

2025-11-20 21:04; UTC

Uždarbis

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

2025-11-20 21:00; UTC

Uždarbis

Intuit Sees 2Q Rev $4.52B-$4.55B >INTU

2025-11-20 21:00; UTC

Uždarbis

Intuit Sees FY26 GAAP Operating Income $5.78B to $5.86B

2025-11-20 21:00; UTC

Uždarbis

Intuit Sees 2Q Adj EPS $3.63-Adj EPS $3.68 >INTU

2025-11-20 21:00; UTC

Uždarbis

Intuit Expects FY26 Global Business Solutions Rev Growth of 15.5% to 16.5%, Excluding Mailchimp

2025-11-20 21:00; UTC

Uždarbis

Intuit Expects FY26 Consumer Rev Growth of 8% to 9%

2025-11-20 21:00; UTC

Uždarbis

Intuit Expects FY26 Global Business Solutions Rev Growth of 14% to 15%

2025-11-20 21:00; UTC

Uždarbis

Intuit Backs FY26 Rev $21B-$21.19B >INTU

2025-11-20 21:00; UTC

Uždarbis

Intuit Backs FY26 Adj EPS $22.98-Adj EPS $23.18 >INTU

2025-11-20 21:00; UTC

Uždarbis

Intuit 1Q Consumer Rev $894M

2025-11-20 21:00; UTC

Uždarbis

Intuit Sees 2Q EPS $1.76-EPS $1.81 >INTU

2025-11-20 21:00; UTC

Uždarbis

Intuit Backs FY26 Guidance

2025-11-20 21:00; UTC

Uždarbis

Intuit Backs FY26 EPS $15.49-EPS $15.69 >INTU

2025-11-20 21:00; UTC

Uždarbis

Intuit 1Q Global Business Solutions Rev $3B

Pharmagest Interactive Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Pharmagest Interactive

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat